487 related articles for article (PubMed ID: 29366648)
1. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
[TBL] [Abstract][Full Text] [Related]
2. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
[TBL] [Abstract][Full Text] [Related]
3. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.
Sasso O; Wagner K; Morisseau C; Inceoglu B; Hammock BD; Piomelli D
Pharmacol Res; 2015 Jul; 97():7-15. PubMed ID: 25882247
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
Wagner K; Yang J; Inceoglu B; Hammock BD
J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
[TBL] [Abstract][Full Text] [Related]
7. Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors.
Kodani SD; Wan D; Wagner KM; Hwang SH; Morisseau C; Hammock BD
ACS Omega; 2018 Oct; 3(10):14076-14086. PubMed ID: 30411058
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.
Guedes A; Galuppo L; Hood D; Hwang SH; Morisseau C; Hammock BD
Equine Vet J; 2017 May; 49(3):345-351. PubMed ID: 27338788
[TBL] [Abstract][Full Text] [Related]
10. Soluble Epoxide Hydrolase Inhibition by
Overby H; Yang Y; Xu X; Graham K; Hildreth K; Choi S; Wan D; Morisseau C; Zeldin DC; Hammock BD; Wang S; Bettaieb A; Zhao L
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987880
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of soluble epoxide hydrolase reduces portal pressure by protecting mesenteric artery myogenic responses in cirrhotic rats.
Huang Y; Qin J; Sun D; Jiang H; Zheng L; He Y; Gui L; Qian B; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():17-24. PubMed ID: 28473204
[TBL] [Abstract][Full Text] [Related]
12. Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation.
Jaiswal S; Tripathi RKP; Ayyannan SR
Biomed Pharmacother; 2018 Nov; 107():1611-1623. PubMed ID: 30257379
[TBL] [Abstract][Full Text] [Related]
13. Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor.
Minaz N; Razdan R; Hammock BD; Mujwar S; Goswami SK
Biomed Pharmacother; 2019 Jul; 115():108897. PubMed ID: 31102913
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis.
Guedes AGP; Aristizabal F; Sole A; Adedeji A; Brosnan R; Knych H; Yang J; Hwang SH; Morisseau C; Hammock BD
J Vet Pharmacol Ther; 2018 Apr; 41(2):230-238. PubMed ID: 29067696
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibitor, t-TUCB, protects against myocardial ischaemic injury in rats.
Shrestha A; Krishnamurthy PT; Thomas P; Hammock BD; Hwang SH
J Pharm Pharmacol; 2014 Sep; 66(9):1251-8. PubMed ID: 24697323
[TBL] [Abstract][Full Text] [Related]
19. Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.
Burmistrov V; Morisseau C; Harris TR; Butov G; Hammock BD
Bioorg Chem; 2018 Feb; 76():510-527. PubMed ID: 29310082
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies of benzothiazole-phenyl analogs as multi-target ligands to alleviate pain without affecting normal behavior.
Angelia J; Weng X; Solomatov A; Chin C; Fernandez A; Hudson PK; Morisseau C; Hammock BD; Kandasamy R; Pecic S
Prostaglandins Other Lipid Mediat; 2023 Feb; 164():106702. PubMed ID: 36529320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]